Commentary By: Anna Dvorak, MDPGY-3
Lung cancer is the number one cause of cancer mortality in both men and women. Screening patients at risk for lung cancer might reduce mortality if it helps find cancers at an early stage while they are still …
Clinical Correlations
The NYU Langone Health Online Journal of Medicine
ShortCuts-This Week in the Journals
April 9, 2007
The April 3rd issue of the Annals provides guidelines for screening mammography in women age 40-49. In the article and an accompanying editorial, the authors suggest that in women younger than age 50, the possible modest benefit of routine mammography screening …
Quick Thinking Part 2
April 6, 2007
Welcome to Quick Thinking a new feature of Clinical Correlations. A case will be presented in short sections to a faculty expert who will comment on their approach to the patient as the case unfolds. These posts will focus on the thought process involved in determining the …
Meeting Perspectives: The 2007 American College of Cardiology Scientific Session
April 5, 2007
Commentary By: Steven Sedlis, MD Associate Professor of Medicine, Chief, Division of Cardiology Manhattan Veterans Administration Medical Center
The 56th annual scientific session of the American College of Cardiology was held in New Orleans on March 24-27. The site of the meeting had …
Book Review: How Doctors Think-Jerome Groopman, MD
April 3, 2007
Commentary By David Shapiro, MD, Former Chief of Allergy and Immunology, Winthrop University Medical Center and New York Ear Infirmary Hospital, Attending Physician OPD Allergy and Immunology, New York Hospital (and most importantly, father of Neil Shapiro, MD)
I highly recommend a new …
ShortCuts: This Week in the Journals
April 2, 2007
JAMA reported on two important “negative” trials: The results of the EVEREST trial, comparing tolvaptan (a novel vasopressin V2 receptor blocker) to placebo for the treatment of acute CHF exacerbation, indicate that this agent had no effect …
Quick Thinking #1
March 30, 2007
Welcome to Quick Thinking a new feature of Clinical Correlations. A case will be presented piece by piece to a faculty expert who will comment on their approach to the case as it unfolds. Differential diagnoses and diagnostic workups will form the basis …
First Direct Renin Inhibitor Approved for Hypertension
March 29, 2007
Commentary By: Josh Olstein, PGY-3
Earlier this month the FDA approved Tekturna (aliskiren) the first drug in a novel class of antihypertensives that work by directly inhibiting renin. While Novartis has yet to release pricing information, don’t expect to see this new …